Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Immunome Q2 Earnings

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.
byBenzinga Insights
August 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.27 which was followed by a 11.81% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Immunome visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cybersecurity Firm Fortinet Q1 Earnings: Product Revenue Falls, Billings Fall, Robust Outlook

By Erica Kollmann
May 2, 5:24 PM
Fortinet reported quarterly earnings of 43 cents per share which beat the analyst consensus estimate of 38 cents by 13.16%. Quarterly sales came in at $1.35 billion, beating the analyst consensus estimate of $1.338 billion and representing a 6.97% increase over sales of $1.262 billion from the same period last year.

CRWD